05-01-202605-01-2026<p>Perinatal Hemolytic Disease is uncommon today due to its prevention. However, there are cases of highly sensitized mothers who wish to have a child, that forces this desired pregnancy to be controlled in a special way and be subjected to invasive procedures not exempt from fetal morbidity and mortality. Prenatal use of human inmunoglobulin in the mother may represent a therapeutic alternative. We present a case in which its use prevented the development of intrauterine disease and favored a good neonatal evolution despite the fact that the initial prognosis was very adverse.</p>info:eu-repo/semantics/openAccessCordocentesisImmunoglobulinIntrauterine transfusionPerinatal hemolytic diseaseRh(D) isoinmmunizationSDG 3 - Good Health and Well-beingArticle